• About us
  • Contact us
  • Our team
  • Terms of Service
Friday, November 13, 2026
Kashmir Images - Latest News Update
Epaper
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER
No Result
View All Result
Kashmir Images - Latest News Update
No Result
View All Result
Home Latest News

Final analysis of Covaxin efficacy out; vaccine 65.2 percent effective against Delta variant

Press Trust of india by Press Trust of india
July 3, 2021
in Latest News, NATION
A A
0
CDSCO panel recommends granting approval for Bharat Biotech’s Covaxin
FacebookTwitterWhatsapp

More News

DGP orders major reshuffle of 136 DySPs

Special DG CRPF meets LG

One killed, several injured in accident in Karnah

Load More

Hyderabad: Bharat Biotech’s Covaxin has

demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and65.2 per cent protection against the new Delta variant.

The company on Saturday said it concluded the final analysis of Covaxin efficacyfrom Phase3 trials.

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases while safety analysis shows adverse events reported were similar to placebo, with 12 per cent of subjects experiencing commonly known side effects and less than 0.5 per cent feeling serious adverse events.

The efficacy data demonstrates 63.6 per cent protection against asymptomatic COVID-19, a release from the city-based vaccine maker said.

Phase 3 clinical trials of the vaccine was an event driven analysis of 130 symptomatic COVID-19 cases, reported at least two weeks after the second dose, conducted at 25 sites across India.

The whole virion inactivated vaccine against SARS-CoV2, was developed inpartnership with Indian Council of Medical Research and National Institute ofVirology in Pune.

Krishna Ella, Chairman and Managing Director of Bharat Biotech, said, “The successful safety and efficacy readouts of Covaxin as a result of conducting the largest ever COVID Vaccines trials in India establishes the ability of India and developing world countries to focus towards innovation and novel product development.

We are proud to state that Innovation from India will now be available to protect global populations.”

Director General of ICMR, Balram Bhargava said, “I am delighted to note that Covaxin developed by ICMR and BBIL under an effective public private partnership, has demonstrated an overall efficacy of 77.8 per cent in Indias largest COVID phase 3 clinical trial thus far.

Our scientists at ICMR and BBIL have worked tirelessly to deliver a truly effective vaccine of highest international standards.”

He further said Covaxin will not only benefit the Indian citizens but would also immensely contribute to protect the global community against the deadly SARS-CoV-2 virus.

“I am also pleased to see that Covaxin works well against all variant strains of SARS-CoV-2.

The successful development of Covaxin has consolidated the position of Indian academia and Industry in the global arena,” Bhargava said.

The Phase 3 trials were conducted between November 16, 2020 and January 7, 2021 with 25,798 participants who were randomised to BBV152 or placebo groups.

The preprint data of COVAXIN efficacy has not been certified by peer-review, according to Medrxiv in which thedata was published.

Previous Post

Eight labourers injured after Tempo turns turtle in Kangan

Next Post

CORRECTION

Press Trust of india

Press Trust of india

Related Posts

DGP orders major reshuffle of 136 DySPs

Govt orders transfers in administration 
November 13, 2026

Srinagar: The Jammu and Kashmir Police Headquarters has ordered the transfer and posting of 136 Deputy Superintendents of Police (DSPs)...

Read moreDetails

Special DG CRPF meets LG

Special DG CRPF meets LG
November 13, 2026

SRINAGAR: Special Director General, CRPF, Jammu and Kashmir Zone, Sandeep Khirwar, on Thursday called on Lieutenant Governor Manoj Sinha here...

Read moreDetails

One killed, several injured in accident in Karnah

1 dead, 14 injured as vehicle falls into gorge in Udhampur
November 13, 2026

KUPWARA: One person was killed and several others injured after a Mahindra Xylo vehicle met with an accident in the...

Read moreDetails

Bandipora-Gurez road closed as snowfall continues at Razdan Pass

Gurez Valley gets grid-connected electricity for the first time 
November 13, 2026

‎Bandipora: Authorities on Thursday suspended vehicular movement on the Bandipora-Gurez road following continuous snowfall at Razdan Pass, citing safety concerns...

Read moreDetails

Take ‘the India Story’ to the world: PM Modi to media

PM to inaugurate five Ladakh projects worth ₹3,350 crore today
November 12, 2026

New Delhi: Prime Minister Narendra Modi on Thursday said the country has fascinating achievements to share with the world and...

Read moreDetails

No dearth of talent in country; students require right opportunities, proper guidance: Prez Murmu

President on 2-day J&K visit from Wednesday
November 12, 2026

New Delhi, Nov 12 (PTI) President Droupadi Murmu on Thursday said there is no dearth of talent in our country...

Read moreDetails
Next Post
CORRECTION

CORRECTION

  • About us
  • Contact us
  • Our team
  • Terms of Service
E-Mailus: kashmirimages123@gmail.com

© 2025 Kashmir Images - Designed by GITS.

No Result
View All Result
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER

© 2025 Kashmir Images - Designed by GITS.